Intrathecal chemokine levels in Alzheimer disease and frontotemporal lobar degeneration

Neurology. 2006 Jan 10;66(1):146-7. doi: 10.1212/01.wnl.0000191324.08289.9d.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age of Onset
  • Aged
  • Alzheimer Disease / cerebrospinal fluid*
  • Alzheimer Disease / diagnosis*
  • Alzheimer Disease / immunology
  • Biomarkers / cerebrospinal fluid
  • Cell Death / immunology
  • Cerebrospinal Fluid / immunology*
  • Chemokine CCL2 / cerebrospinal fluid
  • Chemokines / cerebrospinal fluid*
  • Cognition Disorders / immunology
  • Cognition Disorders / metabolism
  • Cognition Disorders / physiopathology
  • Dementia / cerebrospinal fluid*
  • Dementia / diagnosis*
  • Disease Progression
  • Female
  • Humans
  • Interleukin-8 / cerebrospinal fluid
  • Male
  • Middle Aged
  • Nerve Degeneration / immunology
  • Nerve Degeneration / metabolism
  • Nerve Degeneration / physiopathology
  • Neurons / immunology
  • Neurons / metabolism
  • Neurons / pathology
  • Predictive Value of Tests
  • Sex Factors
  • Spinal Puncture
  • Up-Regulation / immunology

Substances

  • Biomarkers
  • CCL2 protein, human
  • Chemokine CCL2
  • Chemokines
  • Interleukin-8